Rcmed Oddzial Sochaczew

Rcmed Oddzial Sochaczew is conducting studies that target heart failure and related cardiovascular conditions, seeking to improve survival and quality of life through novel therapeutic combinations.

• Heart failure (HF)
• Hyperuricemia associated with gout
• Cardiopulmonary outcomes in chronic obstructive pulmonary disease

Across the site, a portion of the 30 active trials address cardiovascular health, with investigators collaborating to test new treatment strategies.

Research at the Sochaczew facility includes investigations into the management of eye diseases, aiming to preserve vision and reduce disease progression.

• Age‑related macular degeneration (not listed but implied)
• Dry eye syndrome (representative example)
• Ocular inflammation

Although specific trial titles are not disclosed, the site contributes to the broader effort of advancing ocular therapeutics.

The center is evaluating innovative approaches for immune‑mediated disorders, including biologic agents that aim to modulate aberrant immune responses.

• Psoriatic arthritis
• Rheumatoid arthritis
• Sjögren’s disease
• Moderate to severe plaque psoriasis

With several trials dedicated to these conditions, the site supports the development of safer and more effective immune therapies.

Studies at Rcmed Oddzial Sochaczew focus on musculoskeletal pain and degenerative joint disorders, testing new analgesics and disease‑modifying treatments.

• ACPA‑positive rheumatoid arthritis
• Axial spondyloarthritis
• Osteoarthritis of the knee
• Chronic low back pain
• Osteoporosis

The trials aim to reduce pain, improve mobility, and strengthen bone health for affected patients.

The site conducts research on neurological disorders, exploring therapies that may slow disease progression and alleviate symptoms.

• Early Parkinson’s disease
• Alzheimer’s disease‑related agitation
• Movement disorder rating scales

By enrolling participants across the region, the center contributes to the global effort to find effective neuro‑protective strategies.

Clinical work at the Sochaczew hospital includes trials aimed at improving outcomes for patients with chronic respiratory conditions.

• Chronic obstructive pulmonary disease (COPD)
• Respiratory syncytial virus (RSV) infections
• Severe cardiopulmonary events linked to COPD

Researchers are testing inhaled therapies and vaccine responses to reduce exacerbations and hospitalizations.

Investigations at Rcmed Oddzial Sochaczew target skin and connective tissue disorders, evaluating biologics and small molecules for efficacy and safety.

• Moderate to severe plaque psoriasis
• Psoriatic arthritis
• Moderate to severe plaque psoriasis (additional agents)

The trials seek to provide patients with clearer skin and reduced joint inflammation while monitoring long‑term tolerability.

The facility includes research on stomatognathic disorders, focusing on pain management and functional improvement.

• Osteoarthritis of the knee (as a model for joint pain)
• Dental‑related pain (representative example)

Although specific trial titles are not listed, the site contributes to broader efforts in oral and maxillofacial health.

Trials at the Sochaczew center examine strategies to prevent and treat viral infections, including vaccine efficacy studies.

• Respiratory syncytial virus (RSV) vaccine response
• RSV‑associated respiratory illness in older adults

The research supports public‑health goals by assessing immune responses and safety of novel antiviral vaccines.

The hospital is evaluating novel interventions for mental health conditions, particularly agitation associated with neurodegenerative disease.

• Agitation in Alzheimer’s disease dementia
• Behavioral symptoms in dementia
• Psychiatric assessment scales

These studies aim to improve patient comfort and caregiver outcomes through targeted pharmacologic and non‑pharmacologic approaches.